Authors: Liliana Werner, MD, PhD,1,2 Susan Strenk, PhD,3 - PowerPoint PPT Presentation

About This Presentation
Title:

Authors: Liliana Werner, MD, PhD,1,2 Susan Strenk, PhD,3

Description:

... receive in our laboratory a human eye obtained postmortem, implanted with a Pannu IOL. ... available on long-term effects of this lens in the human eye. ... – PowerPoint PPT presentation

Number of Views:54
Avg rating:3.0/5.0
Slides: 13
Provided by: Oli97
Category:
Tags: phd | authors | eye | human | liliana | strenk | susan | werner

less

Transcript and Presenter's Notes

Title: Authors: Liliana Werner, MD, PhD,1,2 Susan Strenk, PhD,3


1
Pathological Analysis of a Pannu Universal IOL
  • Authors Liliana Werner, MD, PhD,1,2 Susan
    Strenk, PhD,3
  • Lawrence Strenk, PhD,3 Don Davis, MD,1
  • Oliver Yeh,1 Nick Mamalis, MD1
  • From the 1) Moran Eye Center, University of
    Utah, Salt Lake City, UT
  • 2) Berlin Eye Research Institute, Berlin, Germany
  • 3) MRI Research, Inc., Cleveland, OH

-Design details of the MRI used are proprietary
to MRI Research Inc. The other authors have no
financial or proprietary interest in any product
mentioned in this poster. -Supported in part by
a Seed Grant of the University of Utah to Liliana
Werner, MD, PhD, and by grants from Alcon
Laboratories, and the National Eye Institute (
R43EY018518) to Susan and Lawrence Strenk.
2
  • In the early 1980s, lenses of a style referred to
    as Universal were designed to be fixated in
    either, the anterior or the posterior chamber.
    One of such lenses was invented by J.S. Pannu
    (Figure 1).1 The flexible loops would allow for
    implantation in eyes of different sizes. The
    rings at the extremities of the loops could be
    used for suturing techniques for fixation of the
    lens in the ciliary sulcus or in the anterior
    chamber.2-3

Figure 1 Figure from the Pannu IOL patent
4,435,855, showing the different sites for
fixation.
3
  • We had the opportunity to receive in our
    laboratory a human eye obtained postmortem,
    implanted with a Pannu IOL.
  • The aim of our study was to provide clinicians
    with the pathological features of this specimen.
  • To the best of our knowledge, this is the only
    report available on long-term effects of this
    lens in the human eye.

4
  • Patient 82-year-old Caucasian man, deceased in
    2007.
  • Lens implanted Single-piece, open-loop, all-PMMA
    IOL, marketed as Universal style (Pannu lens).
  • Manufacturer Unknown.
  • Interval implantation/death of donor Unknown.
    However, as this lens is not in use since the
    late 1980s, we assume the interval was
    approximately 20 years.
  • Laboratory analyses High-resolution anterior
    segment magnetic resonance imaging (MRI) of the
    enucleated eye gross analyses of the anterior
    segment of the eye from the posterior and
    anterior views gross and light microscopic
    analyses of the lens after explantation and
    histopathological analysis of the donor eye.

5
  • MRI examination of the whole eye revealed the
    presence of an IOL with features mostly
    characteristic of a posterior chamber lens, but
    implanted in the anterior chamber with loops
    fixated to the angle. The optic was in a plane
    slightly anterior to the loops, which seemed to
    be pushing onto the iris (Figure 2, arrow). The
    frontal MRI view (Figure 3) showed the loops in a
    counter-clockwise configuration. The lens was
    fairly centered in relation to the pupil.

Figure 2
Figure 3
6
  • Gross examination of the anterior segment from
    anterior (Figures 4 and 5) and posterior (Figures
    6 and 7) views showed significant pigmentary
    dispersion, pupil ovalization, and peripheral
    anterior synechia formation. Two surgical
    iridectomies were apparently performed, and there
    were relatively large areas of transillumination
    defects, some of which coincided with the point
    at which the rings at the extremities of the
    loops were in contact with the iris (arrows).

Figure 4
Figure 6
Figure 5
Figure 7
7
  • Gross (Figure 8) and light microscopy (Figures
    9, 10, and 11) of the lens revealed the presence
    of iris pigments throughout the surface of the
    lens.
  • One of the loops was incarcerated within the iris
    tissue, which remained attached to its surface
    upon explantation (arrows).

Figure 8
Figure 9
Figure 10
Figure 11
8
  • Histopathological examination of multiple
    sections obtained from the enucleated eye showed
    that the cornea was thick, with a significant
    attenuation of the corneal endothelium (Figures
    12, and 13 PAS stain). The anterior chamber
    angle exhibited areas of marked enlargement
    (Figure 14 PAS stain), while other areas had
    peripheral anterior synechiae.

Cornea
Cornea
Corneal endothelium
Iris
Figure 12
Figure 13
Figure 14
9
  • Histopathological examination of multiple
    sections obtained from the enucleated eye also
    showed significant vacuolization within the
    pigmented epithelium of the iris (Figures 15 and
    16 PAS stain). The basement membrane of the
    ciliary body epithelium was somewhat thick, which
    may indicate long-standing diabetes (Figure 17
    PAS stain arrow).

Iris
Iris
Figure 15
Figure 16
Figure 17
10
  • Because the Pannu IOL may still be observed
    clinically on occasion, this report sought to
    present its history and pathological features.
    This case suggests that the IOL may remain
    well-centered over the long term, when implanted
    into the anterior chamber.
  • However, gross and histopathological examination
    revealed that the overall design and fixation
    mechanism of the lens caused long-term trauma
    with significant pigmentary dispersion, among
    other issues. Although unknown in this donor,
    development of further complications, such as
    pigmentary glaucoma remains a possibility.

11
  • The Pannu Universal IOL has design features
    which are overall those of a posterior chamber
    lens. Interestingly, some surgeons worldwide
    would still implant posterior chamber lenses in
    the anterior chamber in cases lacking capsular
    support,4 despite clinical studies describing
    complications such as loop encapsulation by
    peripheral anterior synechiae, recurrent iritis,
    central loop displacement with corneal
    endothelial touch, progressive endothelial cell
    loss and corneal edema, glaucoma, and cystoid
    macular edema.5
  • In conclusion, the Pannu universal IOL has
    probably not been implanted in the US since the
    late 80s. This study shows long-term biologic
    consequences due to its overall design and
    mechanism of fixation. Our findings are relevant,
    considering more recent anecdotal reports of
    implantation of posterior chamber lenses into the
    anterior chamber (cataract_at_lists.ascrs.org).

12
  • 1. Pannu JS, inventor. Universal intraocular lens
    and a method of measuring an eye chamber size. US
    patent 4,435,855. March 13, 1984.
  • 2. Pannu JS. Technique for fixating a subluxated
    posterior chamber lens. J Cataract Refract Surg
    1988 14688-690.
  • 3. Pannu JS. A new suturing technique for ciliary
    sulcus fixation in the absence of posterior
    capsule. Ophthalmic Surg 1988 19751-754.
  • 4. Hara T, Hara T. Ten-year results of anterior
    chamber fixation of the posterior chamber
    intraocular lens. Arch Ophthalmol 2004
    1221112-1116.
  • 5. Koch DD, Wang L.
    Complications of anterior
    chamber fixation of posterior chamber intraocular
    lenses. Arch Ophthalmol 2006 124606-607 author
    reply.
Write a Comment
User Comments (0)
About PowerShow.com